Use of pamidronate for osteoporosis treatment in public health care in Brazil

Conclusion The intravenous pamidronate in a group of postmenopausal women with predominant high risk of fracture promoted an isolated gain in the spine BMD, even though, clinical randomized trials are needed to confirm its anti-fracture efficacy.
Source: Revista Brasileira de Reumatologia - Category: Rheumatology Source Type: research